EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver

Nadine Saber, Mariona Estapé Senti, Raymond M Schiffelers iD

Human Gene Therapy · 2024-09 · 35 (17-18) · 617-627

DOI: 10.1089/hum.2024.106 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 13.09.2024. Verfasst von Nadine Saber und 2 weiteren Autor:innen. Beteiligte Einrichtung: CDL Research, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Nanoparticles, Liver, Lipids, Nucleic Acids. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are the most clinically advanced drug delivery system for nucleic acid therapeutics, exemplified by the success of the COVID-19 mRNA vaccines. However, their clinical use is currently limited to hepatic diseases and vaccines due to their tendency to accumulate in the liver upon intravenous administration. To fully leverage their potential, it is essential to understand and address their liver tropism, while also developing strategies to enhance delivery to tissues beyond the liver. Ensuring that these therapeutics reach their target cells while avoiding off-target cells is essential for both their efficacy and safety. There are three potential targeting strategies—passive, active, and endogenous—which can be used individually or in combination to target nonhepatic tissues. In this review, we delve into the recent advancements in LNP engineering for delivering nucleic acid beyond the liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesLiverLipidsNucleic AcidsHumansSARS-CoV-2Drug Delivery SystemsCOVID-19AnimalsGene Transfer TechniquesCOVID-19 VaccinesLiposomes

Stichwörter der Autor:innen

drug deliveryextrahepatic deliverygene therapylipid nanoparticlenanomedicinenucleic acidtargeted delivery

Substanzen

LipidsNucleic AcidsLipid NanoparticlesCOVID-19 VaccinesLiposomes

Autor:innen und Institutionen

  • CDL Research, University Medical Center Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Raymond M Schiffelers

Zitieren

APA

Saber, N., Senti, M. E., & Schiffelers, R. M. (2024). Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver. Human Gene Therapy, 35(17-18), 617-627. https://doi.org/10.1089/hum.2024.106

Vancouver

Saber N, Senti ME, Schiffelers RM. Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver. Human Gene Therapy. 2024;35(17-18):617-627. doi:10.1089/hum.2024.106

BibTeX
@article{Saber2024,
  author = {Saber, Nadine and Senti, Mariona Estapé and Schiffelers, Raymond M},
  title = {Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver},
  journal = {Human Gene Therapy},
  year = {2024},
  volume = {35},
  number = {17-18},
  pages = {617--627},
  doi = {10.1089/hum.2024.106}
}
Kostenlos starten →